Aligos Therapeutics Inc Share Price

NASDAQ: ALGS

Small Cap

$8.96

-0.41

(-4.34%)

as on September 17, 2025 at 1:29 am IST

$₹

Aligos Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$8.9
Day's Price Range
$9.37
$8.96
0.67%
Downside
4.58%
Upside
52 Week's Low
52 Week's High
$3.76
52-Week Price Range
$46.8
$8.96
58.04%
Downside
422.32%
Upside

Aligos Therapeutics Inc share price movements today

Previous Close: $9.37
Open: $9.37
Volume: 210.4K
Day's Low - High: $8.9 - $9.37
52 Week Low - High: $3.76 - $46.8

Aligos Therapeutics Inc Historical Returns

1 Month Return: + 21.69 %
3 Month Return: + 16.4 %
1 Year Return: -34.11 %
3 Year Return: -67.97 %
5 Year Return: 0 %

Aligos Therapeutics Inc Stock Fundamentals & Key Indicators

Check Aligos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$70.9M

EPS (TTM)

-7.88

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-13.35

Industry PE ratio

-3.947831325301205

P/B Ratio

PEG Ratio

EBITDA

-77.6M

Revenue (TTM)

3.2M

Profit Margin

0.00%

Return On Equity TTM

31922700.00%

Aligos Therapeutics Inc Stock Valuation

Track how Aligos Therapeutics Inc P/E has moved over time to understand its valuation trends.

Aligos Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 16, 2025

Today (-13.35x)

September 16, 2025

Industry (-3.95x)

September 16, 2025

Highest (-0.30x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -13.35x

Aligos Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aligos Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aligos Therapeutics Inc	BUY	$70.9M	NA	-13.35	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Aligos Therapeutics Inc Stock including INR - Dollar returns

The Aligos Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Aligos Therapeutics Inc investment value today

Current value as on today

₹67,877

Returns

₹32,123

(-32.12%)

Returns from Aligos Therapeutics Inc Stock

₹36,990 (-36.99%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Aligos Therapeutics Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Aligos Therapeutics Inc. Average target price of $80.25

Aligos Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Aligos Therapeutics Inc.

What analysts predicted

88.83%UPSIDE

Target Price

$80.25

Current Price

$8.96

Analyzed by

8 Analysts

Target

$80.25

Aligos Therapeutics Inc target price $80.25, a slight upside of 88.83% compared to current price of $8.96. According to 8 analysts rating.

Aligos Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Aligos Therapeutics Inc Stock has increased by 109% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:109% versus previous 30 day period

Aligos Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	2	6	3	2	0	1	1	0	0	0
Gross Profit	1	6	2	1	0	0	1	0	0	0
Operating Income	-21	-19	-19	-25	-22	-26	-20	-20	-19	-18
EBITDA	-23	-18	-18	-27	-21	-26	-19	-19	-18	-15
Interest Expense	1	-	-	1	12	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-22	-18	-18	-27	-34	5	-19	-82	43	-15
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-22	-18	-18	-27	-34	5	-19	-82	43	-15
Net Profit Margin	-843.00%	-272.89%	-556.99%	-1040.36%	-3535.80%	477.00%	-1517.65%	-13060.41%	13854.66%	-1643.83%

Aligos Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-10	4	13	15	3
Gross Profit	-1	-2	-10	4	13	12	3
Operating Income	-13	-54	-97	-128	-97	-88	-89
EBITDA	-12	-49	-94	-124	-93	-85	-89
Interest Expense	-	1	10	0	1	-	-
Depreciation	1	2	3	3	3	3	2
Income Before Tax	-13	-52	-108	-128	-95	-86	-130
Income Tax Expense	0	0	0	0	0	0	0
Net Income	-13	-52	-108	-128	-96	-87	-131
Net Profit Margin	0.00%	0.00%	1029.04%	-2944.07%	-690.63%	-564.61%	-3326.01%

Aligos Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-18	-18	-27	-34	5	-19	-82	43	-15
Operating Cash Flow	-13	-20	-22	-22	-19	-20	-18	-20	-15
Investing Cash Flow	25	0	0	-88	39	10	19	-44	-39
Financing Cash Flow	0	0	87	0	0	0	0	101	0
Change in Cash	11	-20	65	-111	20	-9	1	36	-55

Aligos Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-52	-108	-128	-96	-87	-131
Operating Cash Flow	-46	-74	-115	-79	-78	-80
Investing Cash Flow	6	32	3	-26	44	-18
Financing Cash Flow	85	192	78	0	88	0
Change in Cash	45	150	-33	-105	54	-98

Global Institutional Holdings in Aligos Therapeutics Inc

Funds	Holdings
Adage Capital Partners Gp LLC	7.6%
Deep Track Capital, LP	7.26%
Alyeska Investment Group, L.P.	6.74%
Woodline Partners LP	5.16%
Heights Capital Management Inc	3.95%

See all

Insights on Aligos Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 311.0K → 965.0K (in $), with an average increase of 67.8% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 179.5%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 103.1%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 43.08M → -15.86M (in $), with an average decrease of 136.8% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, ALGS stock has moved down by -12.5%

About Aligos Therapeutics Inc

aligos therapeutics, inc., a biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. its lead drug candidate is alg-010133, a synthetic oligonucleotide that is in phase i clinical trial for the treatment of chronic hepatitis b (chb). the company is also developing alg-000184, a capsid assembly modulator to treat chb; alg-020572, a oligonucleotide for the treatment of chb; alg-125097, an sirna drug candidate to treat chb; and alg-055009, a small molecule thr-ã agonist for the treatment of non-alcoholic steatohepatitis. aligos therapeutics, inc. was founded in 2018 and is headquartered in south san francisco, california.

Organisation	Aligos Therapeutics Inc
Headquarters	One Corporate Drive, South San Francisco, CA, United States, 94080
Industry	Health Technology
CEO	Dr. Lawrence M. Blatt MBA, Ph.D.
E-voting on shares	Click here to vote

Key Management of Aligos Therapeutics Inc

Name	Title
Dr. Julian A. Symons DPHIL	Executive VP & Chief Scientific Officer
Ms. Kristina Engeseth M.B.A.	Senior VP and Head of People & Culture
Dr. Tse-I Lin Ph.D.	Senior VP of Early Compound Development & Belgian Site Head
Dr. Kieron Wesson Ph.D.	Vice President & Head of Chemistry Manufacturing Controls
Ms. Lesley Ann Calhoun CPA	Executive VP, CFO & COO
Ms. Laura Kavanaugh	VP & Head of Legal
Dr. Sushmita M. Chanda DABT, Ph.D.	Executive Vice President & Chief Development Officer
Dr. David B. Smith Ph.D.	Executive VP & Head of Chemical Operations
Dr. Hardean E. Achneck M.D.	Executive VP & Chief Medical Officer
Dr. Lawrence M. Blatt MBA, Ph.D.	CEO, President & Chairman of the Board

FAQs

What is Aligos Therapeutics Inc share price today?

Aligos Therapeutics Inc share price today is $8.96 as on September 17, 2025 at 1:29 am IST at the close of the market. Aligos Therapeutics Inc share today touched a day high of $9.37 and a low of $8.9.

What is the 52 week high and 52 week low for Aligos Therapeutics Inc share?

Aligos Therapeutics Inc share touched a 52 week high of $46.8 on January 6, 2025 and a 52 week low of $3.76 on April 11, 2025. Aligos Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $8.96,which is 80.85% down from its 52 week high and 138.30% up from its 52 week low.

What is Aligos Therapeutics Inc's market capitalisation today?

Aligos Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Aligos Therapeutics Inc Stock (ALGS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aligos Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aligos Therapeutics Inc Shares that will get you 0.1674 shares as per Aligos Therapeutics Inc share price of $8.96 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aligos Therapeutics Inc Stock (ALGS) from India?

Indian investors can start investing in Aligos Therapeutics Inc (ALGS) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 8:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Aligos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 8:44 am IST). Based on Aligos Therapeutics Inc share’s latest price of $8.96 as on September 17, 2025 at 1:29 am IST, you will get 1.1161 shares of Aligos Therapeutics Inc. Learn more about fractional shares .